Understand the latest developments
and industry formats
-
BioSieve™ Fentanyl FIA Home Test Kit and BioSieve™ Toxismart FIA Reader Get FDA Approval for OTC Use
We are proud to announce that VivaChek a leading innovator in diagnostic solutions, has achieved a significant milestone. Our BioSieve™ Fentanyl FIA Home Test Kit and BioSieve™ Toxismart FIA Reader have received FDA approval for over-the-counter (OTC) use, making them the first-ever devices of their kind to reach this milestone.
Read More » -
VivaChek to Present Latest Advancements at Medica 2024 in Düsseldorf
VivaChek announces its participation in Medica 2024, the world’s largest medical trade fair, taking place in Düsseldorf, Germany, from November 11–14, 2024. We will be showcasing our latest developments in Multifunction Monitoring Systems and point-of-care testing (POCT) solutions at Booth No. Hall 3 K52.
Read More » -
VivaChek Opens New Headquarter Campus, Marking a Milestone in Company Growth
On October 10, 2024, VivaChek celebrated a significant milestone with the official inauguration of its new headquarters campus located at 17 Wuzhou Road, Linping District， Hangzhou China. This marks an important step in the company's continuous growth and development within the in vitro diagnostics industry.
Read More » -
VivaChek Biotech Achieves FDA Clearance for Three Innovative Glucose Meters
We are excited to announce that VivaChek Biotech has received FDA clearance for three of its glucose meters featuring advanced FAD enzyme technology. This key milestone underscores the company’s steadfast commitment to driving innovation and maintaining the highest quality standards in healthcare.
Read More » -
VivaChek Achieves 510(k) Clearance for BioSieve™ Fentanyl FIA Test Kit and BioSieve™ Toxismart FIA Reader
We are excited to announce that VivaChek has achieved a significant milestone with the US FDA 510(k) clearance of our BioSieve™ Fentanyl FIA Test Kit and BioSieve™ Toxismart FIA Reader. This groundbreaking approval marks the first of its kind in the United States, setting a new standard in fentanyl detection technology.
Read More » -
VivaChek's VivaDiag Glycosylated Hemoglobin Test Kit Receives IVDR Certification
VivaChek is proud to announce that its VivaDiag Glycosylated Hemoglobin Test Kit has received certification under the In Vitro Diagnostic Regulation (IVDR). This certification, granted in February 2024, underscores our commitment to delivering accurate and reliable diagnostic tools for healthcare professionals.The VivaDiag Glycosylated Hemoglobin Test Kit is designed for the quantitative measurement of glycated hemoglobin (%HbA1c) in human venous whole blood samples
Read More » -
VivaChek Achieves Milestone with IVDR Certification for Two Advanced Glucose Monitoring Systems
VivaChek proudly announces the successful IVDR certification for two of its state-of-the-art glucose monitoring systems. Achieving this milestone on January 25th, 2024, underscores VivaChek's unwavering commitment to delivering accurate and high-quality healthcare solutions for effective diabetes management.The IVDR certification validates the precision and reliability of VivaChek's glucose monitoring systems, reinforcing the company's dedication to maintaining the highest standards of quality and safety. This certification enhances trust in VivaChek's commitment to providing top-tier healthcare solutions...
Read More » -
Vivachek launches a new Lactate Analyzer globally
VivaChek is proudly announces the global launch of the VivaChek Lactate Analyzer, a cutting-edge device meticulously crafted to elevate athletic performance.VivaChek Lactate Analyzer redefines the landscape of sports science, providing athletes with a powerful tool to precisely monitor lactate levels. This innovation facilitates performance optimization, recovery assessment, and the ability to tailor fitness regimes based on individual lactate responses...
Read More » -
VivaChek received FDA 510（K）clearance for VivaChek Link Plus 4G Blood Glucose Monitoring System
We are excited to announce a significant milestone for VivaChek: our revolutionary VivaChek Link Plus Blood Glucose Monitoring System received FDA 510(k) clearance on December 22th. This achievement marks a substantial advancement in diabetes management technology, signifying a noteworthy leap forward in our commitment to innovation and healthcare excellence...
Read More » -
VivaChek Triumphs at Medica 2023, Unveiling Cutting-Edge Solutions for Chronic Disease Management and Diagnostics
Düsseldorf, Germany - VivaChek has emerged triumphant at Medica 2023, unveiling a stellar array of groundbreaking products dedicated to revolutionizing chronic disease management and diagnostic testing. The global healthcare innovator took center stage with a showcase that included the VivaChek Pro Multi-Functional Monitoring System, a 4G-enabled home-use multi-function monitoring system, the VivaDiag FIA Analyzer VIM2000, Drug of Abuse Urine Tests, and a cutting-edge lactate analyzer, reaffirming its commitment to advancing healthcare across diverse domains...
Read More » -
VivaChek launches Five New Products for Monkeypox Virus Test
On May 18, 2022, a U.S. resident was tested positive for monkeypox after returning to the U.S. from Canada, which has attracted extensive attention. In most cases, Monkeypox infection is only found in Africa, thus this case is presumably linked to international travel or imported animals. The Centers for Disease Control and...
Read More » -
VivaDiag™ SARS-CoV-2 IgM/IgG rapid test identified as one of the top-performing COVID-19 antibody POC tests
Feb 10th, 2021, NSF International published results indicating that "Researchers have identified top-performing COVID-19 POC tests", "After screening more than 1,100 independently assessed, point-of-care COVID-19 tests, researchers at NSF International and Novateur Ventures have identified 5 direct (antigen/RNA) tests for detection...
Read More » -
VivaDiag™ SARS-CoV-2 IgM/IgG Rapid Tests have been evaluated by FIND and KU Leuven
Hangzhou & San Diego, July 10, 2020 - in-vitro diagnostic manufacturer VivaChek announced today that the VivaDiag™ SARS-CoV-2 IgM/IgG Rapid Tests have been evaluated by FIND and KU Leuven Belgium recently.On the 13th of March 2020, FIND launched an expression of interest (EOI) process for SARS-CoV-2 antigen or antibody tests...
Read More » -
VivaChek donates 5,040 pcs COVID-19 IgM/IgG rapid test devices to Italy
Hangzhou March 6, 2020 - In-vitro diagnostic manufacturer VivaChek announced today that they have received confirmation letters from the Regional Crisis Centers of Health Department (Assessorato alla sanità-Unità di Crisi) in Italy, to accept and appreciate the donation of 5,040pcs VivaDiag COVID-19 IgM/IgG rapid test devices...
Read More » -
The VivaChek™‘s 6 models BGMS were cleared by the US FDA
FDA (Food and Drug Administration) is the international medical device audit authority, authorized by the US Congress, the federal government, specializing in food and drug management of the highest law enforcement agencies. VivaChek Ino Smart. VivaChek Ino Sync. VivaChek Ino Sound. VivaChek Ino Plus. VivaChek Ino Sound Simple...
Read More » -
The VivaChek™ Ino Blood Glucose Monitoring System was cleared by the USA FDA
FDA (Food and Drug Administration) is the international medical device audit authority, authorized by the US Congress, the federal government, specializing in food and drug management of the highest law enforcement agencies. VivaChekTM Ino Blood Glucose Monitoring System got approved by USA FDA. Hereby attached the certificate.
Read More » -
VivaChek Glucose Monitoring Systems are showing good during inpection of the Minister of Health Moldova
The Republic of Moldova, referred to as "Moldova", is located in the landlocked country of south-east Europe, bordering Romania and Chisinau,Moldova is a former Soviet republic, independent in 1991, is now a member of the Commonwealth of Independent States. A few days ago the VivaChek Glucose Monitoring Systems were inspected by...
Read More » -
Glucowell App Free download from Google Play & Apple Store
Glucowell™ -----Diabetes Management App. SyncAutomatically sync test results from VivaChek Bluetooth glucose meters. ControlGlulcoWell App can track and analyzeglucose, food, meds and sports data, helps you control diabetes more effectively. ShareThe overall glucose report including logbook, can be share to the one who cares you...
Read More » -
VivaChek Ino evaluation is published on the JDST!
VivaChek™ Ino evaluation by IDK Germany is now published on the Journal of Diabetes Science and Technology! The Journal of Diabetes Science and Technology (JDST) is a bi-monthly, peer-reviewed scientific journal published by the Diabetes Technology Society. JDST covers scientific and clinical aspects of diabetes technology...
Read More » -
VivaChek is listed on Drugs Tariff NHS (UK)
The National Health Service (NHS) is the publicly funded healthcare system for the United Kingdom. It is the largest and the oldest single-payer healthcare system in the world. Primarily funded through the general taxation system and overseen by the Department of Health, the system provides healthcare to every legal resident in the United Kingdom, with most services free at the point of use. Some services, such as emergency treatment and treatment of infectious diseases are free for everyone, including visitors. VivaChek is officially listed on Drugs Tariff NHS (UK), which means VivaChek blood glucose meters and test strips are allowed to be distributed freely within NHS system in the UK.
Read More » -
VivaChek is listed with AAH Pharmaceuticals(UK)
The VivaChek test strips and lancets have now been listed with AAH Pharmaceutical. AAH is a pharmaceutical wholesaler in the United Kingdom. Originally formed in 1892 as a company selling solid fuels in South Wales, it was floated on the stock exchange in 1923. It diversified into pharmaceuticals in the 1970s...
Read More » -
VivaChek Singapore and VivaChek India were established
Recently, VivaChek Singapore and VivaChek India were established. VivaChek glucose meters were launched last year, and it has been sold to over 30 countries around the world. The foundation of VivaChek Singapore branch and VivaChek India branch speed up the process of internationalization of VivaChek...
Read More » -
VivaChek Ino BGMS Available on E-commerce Platforms in Europe
VivaChek Ino blood glucose monitoring system has been sold on Bol.com, Cdiscount with high click volume. Bol.com (www.bol.com/nl/index.html) is the leading webshop in the Netherlands，it is the strongest retail brand with the highest expected growth in the Netherlands. VivaChek Ino is also sold on Cdiscount...
Read More » -
VCI BGMS was launched in SriLanka
VivaChek®Ino Blood Glucose Monitoring System was launched last year, the VCI has earned many trust and reputation worldwide by its superior performance. VivaChek®Ino Blood Glucose Monitoring System is the first 8 electrodes Blood Glucose Monitoring System launched in SriLanka, it has been promoted heavily on SriLanka’s leading...
Read More » -
Blood Glucose Monitoring System (BGMS) Business Executives
NOTE: This Job Offer is only for strong; self-confident & determined boys and girls looking for a challenging hardcore sales job. BGMS BUSINESS EXECUTIVE. The job is not easy, and in the end, some may think it is not that rewarding compared to other sales jobs. The job burden is high and for some it may be monotone if they do not...
Read More » -
VivaChek ® Ino BGMS accuracy met the DIN EN ISO 15197:2013 in an independent study in Germany!
VivaChek ® Ino Blood Glucose Monitoring System accuracy met the DIN EN ISO 15197:2013 in an independent clinical study by IDK Germany - Institute of Diabetes »Gerhardt Katsch« Karlsburg (www.diabetes-karlsburg.de) ! The evaluation protocol had been submitted as an amendment to the Independent Ethics Committee Greifswald...
Read More » -
VivaChek receives CE mark for VivaChek™ Ino glucose system
VivaChek today announced that it has received CE Mark (Conformité Européenne) for its VivaChek™ Ino Blood Glucose Monitoring System from TUV Reinland, together with the ISO 13485 certificate for the manufacturing facility. VivaChek™ Ino is an innovative no coding and very user-friendly system meets ALL the requirements of the...
Read More » -
What's your favorable color of VivaChek Ino?
Vote for your favorable color of VivaChek™ Ino! Black, white or gray? Want to participate in a new product development? Make your Vote for us, your Vote Matters! Please leave your comment on VivaChek LinkedIn Page...
Read More » -
Big Success in Arab Health 2015
The world’s 2nd largest healthcare industry show Arab Health 2015 was held in Dubai, United Arab Emirates on January 26-29, 2015. Arab Health 2015 was a big success for VivaChek and we like to say thank you to all our visitors and the very interesting and promising business discussions. Our strong...
Read More » -
VivaChek™ Ino Coming Soon
The VivaChek™ Ino Blood Glucose Monitoring System from VivaChek Labs will be launched very soon. The first batch of samples were sent out today to our clients for trial, and we expect to get feedback in next few weeks. The VivaChek™ Ino Blood Glucose Monitoring System is a very simple and...
Read More » -
Diabetes Day on Its Way
With just 40 days to go to World Diabetes Day on 14 November, here's a reminder of some of the activities that you can do to mark the day in your area: Pin a personality with the blue circle. Light a monument or building in blue, the colour of the global symbol for diabetes awareness...
Read More » -
IDF Diabetes Atlas Update 2012
In 2012 More than 371 million people have diabetes. The number of people with diabetes is increasing in every country. Half of people with diabetes are undiagnosed. 4.8 million people died due to diabetes. More than 471 billion USD were spent on healthcare for diabetes. The IDF Diabetes Atlas 2012 Update generates estimates using new...
Read More »